FDA adds boxed warning to a multiple sclerosis drug, citing rare but severe risk. Today, the FDA issued a warning about the risk of anaphylaxis, a rare but life-threatening allergic reaction ...

The following is a summary of “Chronic graft-versus-host disease myelitis successfully treated with rituximab,” published in ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

Cataracts, a common eye condition characterized by clouding of the lens, often lead to blurred vision and, if left untreated, ...

Recent research highlights a concerning trend: pregnant people with multiple sclerosis are more prone to mental illnesses ...

After a multiple sclerosis diagnosis, travel became nearly impossible for Selma Blair. At California’s iconic — and accessible — Rosewood Miramar Beach, the actor shares her advice on getting back out ...

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

NPR's Steve Inskeep talks to Kevin De Liban, attorney and founder of TechTonic Justice, about how AI comes between Americans and their government.

a rare but severe allergic reaction associated with glatiramer acetate, a medication used to treat relapsing forms of multiple sclerosis (MS). Anaphylaxis can occur at any time during treatment ...

Multiple sclerosis (MS) causes neurological symptoms ... PML is a rare brain infection that usually leads to death or severe disability. Currently, there’s no known treatment for PML.

February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.